Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron fast-dissolving sublingual film for prevention of nausea and vomiting after eye surgery
IRCT20180120038450N2Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Nausea, Retching and 1 more. Started Aug 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180120038450N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180120038450N2.